ArticleJournal of Cancer2019

Efficacy and safety of nimotuzumab in addition to radiotherapy and temozolomide for cerebral glioblastoma: a phase II multicenter clinical trial.

Xiao-Jing Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.